202 related articles for article (PubMed ID: 7985558)
1. Contrast enhancement of brain tumors at different MR field strengths: comparison of 0.5 T and 2.0 T.
Chang KH; Ra DG; Han MH; Cha SH; Kim HD; Han MC
AJNR Am J Neuroradiol; 1994 Sep; 15(8):1413-9; discussion 1420-3. PubMed ID: 7985558
[TBL] [Abstract][Full Text] [Related]
2. MRI evaluation of "solitary" brain metastases with triple-dose gadoteridol: comparison with contrast-enhanced CT and conventional-dose gadopentetate dimeglumine MRI studies in the same patients.
Kuhn MJ; Hammer GM; Swenson LC; Youssef HT; Gleason TJ
Comput Med Imaging Graph; 1994; 18(5):391-9. PubMed ID: 7954317
[TBL] [Abstract][Full Text] [Related]
3. Dose of contrast material in the MR imaging evaluation of central nervous system tumors.
Yuh WT; Halloran JI; Mayr NA; Fisher DJ; Nguyen HD; Simonson TM
J Magn Reson Imaging; 1994; 4(3):243-9. PubMed ID: 8061421
[No Abstract] [Full Text] [Related]
4. MR diagnosis of head and neck tumors: comparison of contrast enhancement with triple-dose gadodiamide and standard-dose gadopentetate dimeglumine in the same patients.
Vogl TJ; Mack MG; Juergens M; Stark M; Pegios W; Bergman C; Grevers G; Western A
AJR Am J Roentgenol; 1994 Aug; 163(2):425-32. PubMed ID: 8037044
[TBL] [Abstract][Full Text] [Related]
5. Echo-planar MR determination of relative cerebral blood volume in human brain tumors: T1 versus T2 weighting.
Bruening R; Kwong KK; Vevea MJ; Hochberg FH; Cher L; Harsh GR; Niemi PT; Weisskoff RM; Rosen BR
AJNR Am J Neuroradiol; 1996 May; 17(5):831-40. PubMed ID: 8733954
[TBL] [Abstract][Full Text] [Related]
6. Effect of dose and field strength on enhancement with paramagnetic contrast media.
Lindsey RO; Yetkin FZ; Prost R; Haughton VM
AJNR Am J Neuroradiol; 1994 Nov; 15(10):1849-52. PubMed ID: 7863934
[TBL] [Abstract][Full Text] [Related]
7. MR evaluation of CNS tumors: dose comparison study with gadopentetate dimeglumine and gadoteridol.
Yuh WT; Fisher DJ; Engelken JD; Greene GM; Sato Y; Ryals TJ; Crain MR; Ehrhardt JC
Radiology; 1991 Aug; 180(2):485-91. PubMed ID: 2068317
[TBL] [Abstract][Full Text] [Related]
8. A comparative study on contrast enhancement between 0.5- and 2.0-Tesla field strength in rabbit VX2 carcinomas.
Ra DG; Chang KH; Han MH; Lee HJ; Yeon KM
Invest Radiol; 1995 May; 30(5):291-5. PubMed ID: 7558733
[TBL] [Abstract][Full Text] [Related]
9. Comparative evaluation of lesion enhancement using 1 M gadobutrol vs. 2 conventional gadolinium chelates, all at a dose of 0.1 mmol/kg, in a rat brain tumor model at 3 T.
Attenberger UI; Runge VM; Jackson CB; Baumann S; Birkemeier K; Michaely HJ; Schoenberg SO; Reiser MF; Wintersperger BJ
Invest Radiol; 2009 May; 44(5):251-6. PubMed ID: 19550376
[TBL] [Abstract][Full Text] [Related]
10. Comparison of gadobenate dimeglumine (Gd-BOPTA) with gadopentetate dimeglumine (Gd-DTPA) for enhanced MR imaging of brain and spine tumours in children.
Colosimo C; Demaerel P; Tortori-Donati P; Christophe C; Van Buchem M; Högström B; Pirovano G; Shen N; Kirchin MA; Spinazzi A
Pediatr Radiol; 2005 May; 35(5):501-10. PubMed ID: 15678342
[TBL] [Abstract][Full Text] [Related]
11. Effect of the rate of gadopentetate dimeglumine administration on abdominal vascular and soft-tissue MR imaging enhancement patterns.
Strouse PJ; Prince MR; Chenevert TL
Radiology; 1996 Dec; 201(3):809-16. PubMed ID: 8939236
[TBL] [Abstract][Full Text] [Related]
12. Administration of gadopentetate dimeglumine in MR imaging of intracranial tumors: dosage and field strength.
Haustein J; Laniado M; Niendorf HP; Hilbertz T; Planitzer J; Schörner W; Louton T
AJNR Am J Neuroradiol; 1992; 13(4):1199-206. PubMed ID: 1636537
[TBL] [Abstract][Full Text] [Related]
13. Multicenter, double-blind, randomized, intra-individual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine in MRI of brain tumors at 3 tesla.
Rumboldt Z; Rowley HA; Steinberg F; Maldjian JA; Ruscalleda J; Gustafsson L; Bastianello S
J Magn Reson Imaging; 2009 Apr; 29(4):760-7. PubMed ID: 19306364
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of gadobutrol, a macrocyclic, nonionic gadolinium chelate in a brain glioma model: comparison with gadoterate meglumine and gadopentetate dimeglumine at 1.5 T, combined with an assessment of field strength dependence, specifically 1.5 versus 3 T.
Attenberger UI; Runge VM; Morelli JN; Williams J; Jackson CB; Michaely HJ
J Magn Reson Imaging; 2010 Mar; 31(3):549-55. PubMed ID: 20187196
[TBL] [Abstract][Full Text] [Related]
15. Measurement of cerebral blood volume via the relaxing effect of low-dose gadopentetate dimeglumine during bolus transit.
Hackländer T; Reichenbach JR; Hofer M; Mödder U
AJNR Am J Neuroradiol; 1996 May; 17(5):821-30. PubMed ID: 8733953
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Low-Dose Higher-Relaxivity and Standard-Dose Lower-Relaxivity Contrast Media for Delayed-Enhancement MRI: A Blinded Randomized Crossover Study.
Cheong BY; Duran C; Preventza OA; Muthupillai R
AJR Am J Roentgenol; 2015 Sep; 205(3):533-9. PubMed ID: 26295638
[TBL] [Abstract][Full Text] [Related]
17. Postoperative evaluation for intracranial recurrence of medulloblastoma: MR findings with gadopentetate dimeglumine.
Meyers SP; Wildenhain S; Chess MA; Tarr RW
AJNR Am J Neuroradiol; 1994 Sep; 15(8):1425-34. PubMed ID: 7985559
[TBL] [Abstract][Full Text] [Related]
18. Brain metastases--comparison of gadodiamide injection-enhanced MR imaging at standard and high dose, contrast-enhanced CT and non-contrast-enhanced MR imaging.
Akeson P; Larsson EM; Kristoffersen DT; Jonsson E; Holtås S
Acta Radiol; 1995 May; 36(3):300-6. PubMed ID: 7742127
[TBL] [Abstract][Full Text] [Related]
19. Contrast-to-Dose Relationship of Gadopiclenol, an MRI Macrocyclic Gadolinium-based Contrast Agent, Compared with Gadoterate, Gadobenate, and Gadobutrol in a Rat Brain Tumor Model.
Robert P; Vives V; Grindel AL; Kremer S; Bierry G; Louin G; Ballet S; Corot C
Radiology; 2020 Jan; 294(1):117-126. PubMed ID: 31660804
[TBL] [Abstract][Full Text] [Related]
20. MR of intracranial tumors: combined use of gadolinium and magnetization transfer.
Kurki T; Niemi P; Valtonen S
AJNR Am J Neuroradiol; 1994 Oct; 15(9):1727-36. PubMed ID: 7847221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
